Insufficient scRNA-seq data for expression of SNX33 at single-cell level.
Insufficient scRNA-seq data for expression of SNX33 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6135.28 | 1445 / 1445 | 100% | 23.98 | 183 / 183 |
prostate | 100% | 5480.50 | 245 / 245 | 100% | 25.65 | 502 / 502 |
breast | 100% | 5164.31 | 459 / 459 | 100% | 22.57 | 1117 / 1118 |
intestine | 100% | 4631.57 | 966 / 966 | 100% | 18.82 | 526 / 527 |
skin | 100% | 5615.06 | 1809 / 1809 | 100% | 26.34 | 471 / 472 |
uterus | 100% | 6219.57 | 170 / 170 | 100% | 27.51 | 458 / 459 |
lung | 100% | 4678.12 | 578 / 578 | 100% | 22.19 | 1152 / 1155 |
thymus | 100% | 4333.94 | 652 / 653 | 100% | 26.10 | 604 / 605 |
stomach | 100% | 3690.55 | 359 / 359 | 99% | 18.58 | 284 / 286 |
kidney | 100% | 2639.08 | 89 / 89 | 99% | 35.12 | 894 / 901 |
pancreas | 100% | 3315.40 | 328 / 328 | 99% | 26.72 | 176 / 178 |
liver | 100% | 2516.95 | 225 / 226 | 99% | 15.56 | 403 / 406 |
bladder | 100% | 4961.81 | 21 / 21 | 98% | 22.55 | 496 / 504 |
ovary | 100% | 6055.40 | 180 / 180 | 98% | 14.30 | 421 / 430 |
brain | 87% | 1279.03 | 2289 / 2642 | 100% | 17.97 | 703 / 705 |
adrenal gland | 100% | 3571.18 | 258 / 258 | 79% | 8.50 | 182 / 230 |
adipose | 100% | 5769.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7731.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.06 | 1 / 1 |
spleen | 100% | 2643.15 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 2576.08 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 22.94 | 79 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 9.05 | 25 / 29 |
muscle | 45% | 536.55 | 358 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 26.85 | 27 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0044351 | Biological process | macropinocytosis |
GO_0017038 | Biological process | protein import |
GO_0006897 | Biological process | endocytosis |
GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
GO_0045806 | Biological process | negative regulation of endocytosis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0097320 | Biological process | plasma membrane tubulation |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0016197 | Biological process | endosomal transport |
GO_0007032 | Biological process | endosome organization |
GO_2000009 | Biological process | negative regulation of protein localization to cell surface |
GO_0036089 | Biological process | cleavage furrow formation |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005829 | Cellular component | cytosol |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SNX33 |
Protein name | Sorting nexin 33 Sorting nexin-33 (SH3 and PX domain-containing protein 3) Alternative protein SNX33 |
Synonyms | SH3PX3 SNX30 SH3PXD3C |
Description | FUNCTION: Plays a role in the reorganization of the cytoskeleton, endocytosis and cellular vesicle trafficking via its interactions with membranes, WASL, DNM1 and DNM2. Acts both during interphase and at the end of mitotic cell divisions. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Modulates endocytosis of cell-surface proteins, such as APP and PRNP; this then modulates the secretion of APP and PRNP peptides. Promotes membrane tubulation (in vitro). May promote the formation of macropinosomes. . |
Accessions | L8E981 ENST00000308527.6 Q8WV41 H3BPR3 ENST00000569152.1 |